Celyad Stock Story

CYAD -  USA Stock  

USD 3.69  0.14  3.94%

Celyad Sa Average Equity is projected to increase significantly based on the last few years of reporting. The past year's Average Equity was at 38.31 Million. The current year Enterprise Value is expected to grow to about 122.8 M, whereas Earnings before Tax are forecasted to decline to (18.6 M). The underlying objective of this short story is to digest Celyad as an investment oportunity for January. We will discuss why recent Celyad Sa price moves suggest a bounce in January.
Published over a month ago
View all stories for Celyad Sa | View All Stories
Should you continue to rely on Celyad Sa (NASDAQ:CYAD) management?
About 7.0% of Celyad Sa shares are held by institutions such as insurance companies. Insiders ownership of Celyad Sa ADR refers to the amount of Celyad Sa ADR equity owned by Celyad officers, directors, relatives of the leadership team, or anyone who has access to private information before it's made available to the public. Check out our latest analysis of Celyad, including its current ownership diagnostics.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Celyad Sa ADR. Regardless of method or technology, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for Celyad Sa

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Celyad Sa's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Celyad Sa in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Celyad Sa. Your research has to be compared to or analyzed against Celyad Sa's peers to derive any actionable benefits. When done correctly, Celyad Sa's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Celyad Sa ADR.

How important is Celyad Sa's Liquidity

Celyad Sa financial leverage refers to using borrowed capital as a funding source to finance Celyad Sa ADR ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Celyad Sa financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Celyad Sa's total debt and its cash.

How does Celyad utilize its cash?

To perform a cash flow analysis of Celyad Sa, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Celyad Sa is receiving and how much cash it distributes out in a given period. The Celyad Sa cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Celyad Sa Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (24.9 Million)

Breaking down Celyad Sa Indicators

The modest gains experienced by current holders of Celyad Sa could raise concerns from shareholders as the firm it trading at a share price of 4.70 on 55,865,951 in volume. The company management teams have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in November. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.0. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Celyad Sa partners.

Returns Breakdown

Return on Assets(0.24)
Return on Equity(0.48)
Return Capital(3.23)
Return on Sales(3,618.79)

Another 3 percent surge for Celyad Sa

Latest Risk Adjusted Performance is up to -0.07. Price may dip again.
As of the 3rd of December, Celyad Sa shows the risk adjusted performance of (0.07), and Mean Deviation of 2.25. Celyad Sa ADR technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Celyad Sa ADR, which can be compared to its rivals. Please confirm Celyad Sa ADR treynor ratio, and the relationship between the variance and potential upside to decide if Celyad Sa ADR is priced correctly, providing market reflects its regular price of 4.7 per share. Given that Celyad Sa has jensen alpha of (0.25), we suggest you to validate Celyad Sa ADR's prevailing market performance to make sure the company can sustain itself at a future point.

Our Final Take On Celyad Sa

Although few other entities within the biotechnology industry are still a little expensive, even after the recent corrections, Celyad Sa may offer a potential longer-term growth to shareholders. With an impartial outlook on the current market volatility, it may be better to hold off any inventment activity and neither acquire nor drop any shares of Celyad Sa at this time. The Celyad Sa ADR risk-reward trade off is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Celyad Sa.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Celyad Sa ADR. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com